Nu-Med Plus (NUMD) Invested Capital (2011 - 2025)
Nu-Med Plus recorded quarterly Invested Capital of -$271278.0 in Q4 2025, down 4.88% quarter-over-quarter from -$258660.0 in Q3 2025, and down 26.12% year-over-year from -$367184.8 in Q4 2024.
Nu-Med Plus' Invested Capital history runs 15 years deep, the most recent figure standing at -$271278.0 for Q4 2025.
- In Q4 2025, Invested Capital fell 26.12% year-over-year to -$271278.0; the TTM figure through Dec 2025 stood at -$271278.0 (down 26.12% YoY), while the FY2025 annual figure was -$271278.0, down 26.12% from the prior year.
- Invested Capital came in at -$271278.0 for Q4 2025 at Nu-Med Plus, down from -$258660.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $190955.0 in Q1 2021 to a low of -$271278.0 in Q4 2025.
- A 5-year average of -$152677.1 and a median of -$177220.5 in 2024 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital jumped 176.67% in 2021 and plunged 14865.54% in 2022, its largest moves.
- Nu-Med Plus' Invested Capital stood at -$132358.0 in 2021, then soared by 52.38% to -$63025.0 in 2022, then slumped by 132.85% to -$146751.0 in 2023, then tumbled by 46.57% to -$215096.0 in 2024, then slipped by 26.12% to -$271278.0 in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered -$271278.0, -$258660.0, and -$246694.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 86.11 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 23.48 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.39 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 20.80 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9.01 Bn |
| 10 | Nu-Med Plus | - | - | - | -271,278.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -271,278.00 |
| Sep 30, 2025 | -258,660.00 |
| Jun 30, 2025 | -246,694.00 |
| Mar 31, 2025 | -235,029.00 |
| Dec 31, 2024 | -215,096.00 |
| Sep 30, 2024 | -204,541.00 |
| Jun 30, 2024 | -185,864.00 |
| Mar 31, 2024 | -168,577.00 |
| Dec 31, 2023 | -146,751.00 |
| Sep 30, 2023 | -131,955.00 |
| Jun 30, 2023 | -115,549.00 |
| Mar 31, 2023 | -91,229.00 |
| Dec 31, 2022 | -63,025.00 |
| Sep 30, 2022 | -270,131.00 |
| Jun 30, 2022 | -247,081.00 |
| Mar 31, 2022 | -189,011.00 |
| Dec 31, 2021 | -132,358.00 |
| Sep 30, 2021 | -70,017.00 |
| Jun 30, 2021 | -1,651.00 |
| Mar 31, 2021 | 190,955.00 |
| Dec 31, 2020 | 467,703.00 |
| Sep 30, 2020 | 338,014.00 |
| Jun 30, 2020 | 523,860.00 |
| Mar 31, 2020 | -249,075.00 |
| Dec 31, 2019 | -256,201.00 |
| Sep 30, 2019 | -303,412.00 |
| Jun 30, 2019 | -307,254.00 |
| Mar 31, 2019 | -224,668.00 |
| Dec 31, 2018 | 59,486.00 |
| Sep 30, 2018 | 203,883.00 |
| Jun 30, 2018 | -15,430.00 |
| Mar 31, 2018 | -11,625.00 |
| Dec 31, 2017 | 77,641.00 |
| Sep 30, 2017 | 54,374.00 |
| Jun 30, 2017 | -87,598.00 |
| Mar 31, 2017 | -36,650.00 |
| Dec 31, 2016 | -4.44 Mn |
| Sep 30, 2016 | -136,608.00 |
| Jun 30, 2016 | 577,699.00 |
| Mar 31, 2016 | -253,786.00 |
| Dec 31, 2015 | -15.22 Mn |
| Sep 30, 2015 | -216,005.00 |
| Jun 30, 2015 | -184,928.00 |
| Mar 31, 2015 | -175,950.00 |
| Dec 31, 2014 | -7.11 Mn |
| Sep 30, 2014 | -53,766.00 |
| Jun 30, 2014 | 284,427.00 |
| Mar 31, 2014 | 244,059.00 |
| Dec 31, 2013 | -124,339.00 |
| Sep 30, 2013 | -145,695.00 |
| Jun 30, 2013 | -49,797.00 |
| Mar 31, 2013 | -51,142.00 |
| Dec 31, 2012 | -7,584.00 |
| Dec 31, 2011 | 1,406.00 |